Madison Square Garden (NYSE:MSGS – Get Free Report) had its target price increased by research analysts at Susquehanna from $430.00 to $477.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage presently has a “positive” rating on the stock. Susquehanna’s price target points to a potential upside of 17.96% from the stock’s current price.
Other equities analysts have also issued research reports about the stock. Morgan Stanley upgraded shares of Madison Square Garden from an “equal weight” rating to an “overweight” rating and set a $450.00 price target on the stock in a report on Wednesday, July 15th. JPMorgan Chase & Co. upped their price objective on Madison Square Garden from $400.00 to $450.00 and gave the stock an “overweight” rating in a report on Tuesday, July 21st. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Madison Square Garden in a research report on Wednesday, June 24th. Citigroup lifted their target price on Madison Square Garden from $355.00 to $360.00 and gave the company a “neutral” rating in a report on Wednesday, May 13th. Finally, Zacks Research lowered Madison Square Garden from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 16th. Four equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Madison Square Garden currently has an average rating of “Hold” and an average price target of $464.20.
View Our Latest Analysis on MSGS
Madison Square Garden Stock Performance
Hedge Funds Weigh In On Madison Square Garden
Several hedge funds and other institutional investors have recently made changes to their positions in the business. Price T Rowe Associates Inc. MD increased its holdings in Madison Square Garden by 67.7% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 699,378 shares of the company’s stock valued at $180,895,000 after purchasing an additional 282,318 shares in the last quarter. T. Rowe Price Investment Management Inc. lifted its stake in shares of Madison Square Garden by 8.2% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 648,515 shares of the company’s stock worth $167,739,000 after purchasing an additional 49,412 shares in the last quarter. Gamco Investors INC. ET AL boosted its position in shares of Madison Square Garden by 1.1% in the fourth quarter. Gamco Investors INC. ET AL now owns 613,391 shares of the company’s stock worth $158,654,000 after buying an additional 6,873 shares during the period. State Street Corp boosted its position in shares of Madison Square Garden by 3.0% in the fourth quarter. State Street Corp now owns 538,404 shares of the company’s stock worth $139,258,000 after buying an additional 15,656 shares during the period. Finally, Gabelli Funds LLC grew its stake in shares of Madison Square Garden by 0.9% in the fourth quarter. Gabelli Funds LLC now owns 394,292 shares of the company’s stock valued at $101,984,000 after buying an additional 3,607 shares in the last quarter. Institutional investors and hedge funds own 68.94% of the company’s stock.
Key Headlines Impacting Madison Square Garden
Here are the key news stories impacting Madison Square Garden this week:
- Positive Sentiment: MSGS reported fourth-quarter earnings of approximately $1.16–$1.19 per share, well above analyst expectations of $0.64–$0.72. Revenue reached $278.75 million, exceeding the $227.67 million consensus estimate and rising 36.6% from the prior year. Madison Square Garden Sports earnings results
- Positive Sentiment: Coverage attributed the quarterly beat to the Knicks’ championship, which likely supported higher ticket demand, premium seating, sponsorship, merchandising and related revenue. The earnings release and conference call provide additional details on the fiscal 2026 fourth quarter and full-year performance. Madison Square Garden Sports fiscal 2026 results
- Neutral Sentiment: The earnings call and related coverage give investors more information about management’s outlook, but the available reports do not identify a major new long-term catalyst beyond the Knicks’ recent success. MSGS was already trading well above its 50-day and 200-day moving averages and near its 52-week high, which may raise the bar for future results.
- Neutral Sentiment: Reports about Travis Kelce and Taylor Swift holding a wedding at Madison Square Garden provide publicity for the venue, but they appear more relevant to Madison Square Garden Entertainment than to MSGS, whose primary assets are the Knicks and New York Rangers. Travis Kelce and Taylor Swift wedding report
- Negative Sentiment: One analyst argued that a Knicks championship alone does not establish an attractive investment case, cautioning that the strong results may reflect a temporary sports-driven boost rather than sustainable earnings growth. Investors may therefore focus on recurring revenue, valuation and performance after the championship effect fades. Analysis of MSGS investment case
Madison Square Garden Company Profile
Madison Square Garden Sports Corp (NYSE: MSGS) is a leading sports and entertainment holding company focused on professional sports franchises and related media assets. The company owns and operates teams such as the NBA’s New York Knicks, the NHL’s New York Rangers and the WNBA’s New York Liberty. Through these flagship franchises, MSG Sports offers a range of products and services including ticketing, premium seating and sponsorship opportunities, targeting fans in the New York metropolitan area and beyond.
In addition to team operations, Madison Square Garden Sports Corp holds a majority stake in MSG Networks, a regional cable network that broadcasts live sporting events, news and original programming.
Further Reading
- Five stocks we like better than Madison Square Garden
- Joint Operations: Curaleaf Makes a Play for Aurora Cannabis
- Cerebras Sells Off After Earnings: Is This a Market Disconnection?
- Is Lockheed Martin Gearing Up to Lead Defense Stocks?
- Inside Teledyne’s Bold Bet on the Future of Medical Imaging
Receive News & Ratings for Madison Square Garden Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Madison Square Garden and related companies with MarketBeat.com's FREE daily email newsletter.
